Venclexta (venetoclax)

pCPA File Number: 22952

Negotiation Status:

Active Negotiation

Indication(s):

In combination with Gazyva, for the treatment of patients with previously untreated chronic lymphocytic leukemia

Sponsor/Manufacturer:

AbbVie Corporation

CDA-AMC Project Number:

PC0362-000

pCPA Engagement Letter Issued:

2025-02-10

Negotiation Process Concluded:

Not Applicable